| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/09/2003 | WO2003001907A1 Nmp35 apoptosis inhibitor gene disruptions compositions and methods related thereto |
| 01/09/2003 | WO2003001902A2 Alteration of oil traits in plants |
| 01/09/2003 | WO2003001883A2 Gaba b1a receptor disruptions, compositions and methods relating thereto |
| 01/09/2003 | WO2003001882A2 Putative neurotransmitter receptor (pnr) disruptions, compositions and methods relating thereto |
| 01/09/2003 | WO2003001881A2 Cell-based high-throughput screening methods |
| 01/09/2003 | WO2003001880A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/09/2003 | WO2003001877A2 Methods for the diagnosis and treatment of cardiac tissue rejection |
| 01/09/2003 | WO2003001876A2 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 01/09/2003 | WO2003001863A2 Novel endothelially expressed dnas and proteins, and their use |
| 01/09/2003 | WO2002090491A3 Modification of metal-handling in plants |
| 01/09/2003 | WO2002089727A9 Methods of using cytokine c17 |
| 01/09/2003 | WO2002083707A9 Tub antisense constructs |
| 01/09/2003 | WO2002078630A8 Tub 3'-variant |
| 01/09/2003 | WO2002077195A9 Plasmodium falciparum ama-1 protein and uses thereof |
| 01/09/2003 | WO2002074796A3 Histidine phosphatase interacting protein with 240kd |
| 01/09/2003 | WO2002066651A3 Nucleotide sequences of the ribosomal protein s12 gene (rpsl) from corynebacterium glutamicum |
| 01/09/2003 | WO2002055658A3 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 01/09/2003 | WO2002048335A9 Metal resistant plants and use for phytoremediation |
| 01/09/2003 | WO2002048189A3 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 01/09/2003 | WO2002046423A3 Protein derived from the melanin-concentrating hormone (mch), corresponding nucleic acids and their use for preparing medicines |
| 01/09/2003 | WO2002043756A3 Method for obtaining antigenic aggregates and the use thereof in formulations |
| 01/09/2003 | WO2002038769A3 Dna sequences, which code for optimised eukaryotic hpv 16-l1 and hpv 16-l2 |
| 01/09/2003 | WO2002036793A3 Secreted protein associated with depression; composition and methods of use thereof |
| 01/09/2003 | WO2002036625A3 Prokineticin polypeptides, related compositions and methods |
| 01/09/2003 | WO2002032946A8 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae |
| 01/09/2003 | WO2002032943A3 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 01/09/2003 | WO2002029039A3 47316, a novel human g-protein and uses therefor |
| 01/09/2003 | WO2002028175A3 Transgenic mouse for targeted recombination mediated by modified cre-er |
| 01/09/2003 | WO2002024726A3 Olfactory and pheromones g-protein coupled receptors |
| 01/09/2003 | WO2002020558A3 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 01/09/2003 | WO2002020041A3 Eia vaccine and diagnostic |
| 01/09/2003 | WO2002018569A3 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures |
| 01/09/2003 | WO2002016655A9 Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
| 01/09/2003 | WO2002013855A3 Vaccines containing ribavirin and methods of use thereof |
| 01/09/2003 | WO2002012526A3 Materials and methods for delivery and expression of heterologous dna in vertebrate cells |
| 01/09/2003 | WO2002012327A3 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 01/09/2003 | WO2002012282A3 Novel ebi-3-alt protein and nucleic acid molecules and uses therefor |
| 01/09/2003 | WO2002011756A3 Anti-plasmodium compositions and methods of use |
| 01/09/2003 | WO2002010203A3 Daz genes |
| 01/09/2003 | WO2002008407A3 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| 01/09/2003 | WO2002008283A3 Lp120 polypeptides and therapeutic uses thereof |
| 01/09/2003 | WO2002008251A3 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/09/2003 | WO2002006461A3 Inhibitors of plant peptide deformylase for use as broad-spectrum herbicides and methods for identifying the same |
| 01/09/2003 | WO2002004518A3 Human neuropeptide y-like g protein-coupled receptor |
| 01/09/2003 | WO2002004510A3 Gtp-binding proteins |
| 01/09/2003 | WO2002000697A3 Bonsai, a phospholipid binding protein, is required for thermal tolerance in arabidopsis |
| 01/09/2003 | WO2002000017A3 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 01/09/2003 | WO2001098480A3 Promoters for regulation of plant gene expression |
| 01/09/2003 | WO2001098351A3 G-protein coupled receptors |
| 01/09/2003 | WO2001081376A3 Apo-ai/aii peptide derivatives |
| 01/09/2003 | WO2001079480A9 Albumin fusion proteins |
| 01/09/2003 | WO2001070776A3 Nimr compositions and their methods of use |
| 01/09/2003 | WO2001068841A3 Human dcc-like proteins |
| 01/09/2003 | WO2001066801A3 Very low density lipoprotein receptor polymorphisms and uses therefor |
| 01/09/2003 | WO2001066598A9 Chemoattractant receptor characterization and cell selection materials and methods and chemokine receptor ccr11 materials and methods |
| 01/09/2003 | WO2001057278A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human hela cells or other human cervical epithelial cells |
| 01/09/2003 | WO2001057276A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow |
| 01/09/2003 | WO2001057267A9 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 01/09/2003 | WO2001055336A9 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/09/2003 | WO2001055333A9 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 01/09/2003 | US20030009785 Plant cytoprotective genes and methods of using same |
| 01/09/2003 | US20030009782 Compositions and methods for fumonisin detoxification |
| 01/09/2003 | US20030009781 Animal model for use in the treatment of pain and anxiety disorders |
| 01/09/2003 | US20030009780 Animal models for use as tools in the diagnosis, prevention and treatment of nervous system and psychological disorders |
| 01/09/2003 | US20030009778 Expresion vector for use in the generation of animal for evaluating bone and kidney disorders |
| 01/09/2003 | US20030009777 Using galanin agonist in the generation of medicament for the treatment of nerve damage |
| 01/09/2003 | US20030009774 Trangenic rodent for use as model in evaluation of xenobiotics |
| 01/09/2003 | US20030009026 Insertion sequence element derived from ralstonia solanacearum |
| 01/09/2003 | US20030009025 For vaccination against botulism |
| 01/09/2003 | US20030009024 46584, a human transporter family member and uses therefor |
| 01/09/2003 | US20030009023 Isolation and method of using tissue growth-inducing Frzb protein |
| 01/09/2003 | US20030009022 Methods and compositions for identifying receptor effectors |
| 01/09/2003 | US20030009020 Gene originating in human chondrocyte |
| 01/09/2003 | US20030009018 Novel hemopoietin receptor protein, NR12 |
| 01/09/2003 | US20030009017 For diagnosis and therapy of cancer or aberrant cellular proliferation and/or differentiation, immune disorders, heart disorders, cardiovascular disorders, including endothelial cell disorders, hematopoietic and blood vessel disorder |
| 01/09/2003 | US20030009015 Bacterial superantigen vaccines |
| 01/09/2003 | US20030009013 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030009012 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030009010 As vaccines for therapy and prophylaxis of Haemophilus influenzae infection |
| 01/09/2003 | US20030009009 Modified cytokine receptor protein |
| 01/09/2003 | US20030008840 Methods for treating cancer |
| 01/09/2003 | US20030008837 Therapy |
| 01/09/2003 | US20030008827 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 01/09/2003 | US20030008823 For determining ligand binding, detecting expression, drug screening, and treatment involving the human 5-HT1F receptor |
| 01/09/2003 | US20030008820 Methods and products related to FGF dimerization |
| 01/09/2003 | US20030008819 Targeting endothelium for tissue-specific delivery of agents |
| 01/09/2003 | US20030008816 Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| 01/09/2003 | US20030008815 For diagnosis and therapy of immune related disease in mammals, including humans; tumor therapy |
| 01/09/2003 | US20030008813 Intracellular protein delivery compositions and methods of use |
| 01/09/2003 | US20030008415 Determination of protein s concentration; obtain ligand, incubate with sample, detect complex formation, determine protein concentration |
| 01/09/2003 | US20030008391 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008380 Gnetically engineered cells for use in the generation of heterologous proteins |
| 01/09/2003 | US20030008376 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008375 Generation of preferential adenoviral expression vector; obtain cells, infect with virus, harvest and lyse cell, recover vectors |
| 01/09/2003 | US20030008373 APOA1-interacting proteins and use thereof |
| 01/09/2003 | US20030008369 Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases |
| 01/09/2003 | US20030008367 Isolation and purification of clostridium botulinum toxins |
| 01/09/2003 | US20030008357 Polypeptide for use in the treatment of inflammation, rheumatoid arritis, psoriasis, and diabetic retinopathy |
| 01/09/2003 | US20030008356 Novel polypeptide, a cDNA encoding the same, and use of it |
| 01/09/2003 | US20030008353 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors |